Publications by authors named "Harrison Moosavi"

Article Synopsis
  • * A multi-institutional study involving 166 patients with estrogen receptor positive, HER2-negative breast cancers examined ME3's effectiveness in predicting pathologic complete response (pCR) to neoadjuvant chemotherapy.
  • * Results indicated that higher ME3 scores correlated with increased pCR rates and better outcomes, reinforcing ME3's predictive and potentially prognostic capabilities, especially in patients with residual disease.
View Article and Find Full Text PDF

Background: The PLASMIC score is a rapid and inexpensive tool for predicting severe ADAMTS13 deficiency (activity <10%) in patients with suspected thrombotic thrombocytopenic purpura (TTP) by analyzing seven parameters (platelet count; combined hemolysis variable; absence of active neoplasia; absence of an organ or stem-cell transplant; mean corpuscular value; international normalized ratio; and serum creatinine). The purpose of this study was to validate the PLASMIC score at a large multi-institutional academic medical center.

Methods: An internal database of consultations to the transfusion medicine service, which oversees therapeutic apheresis at our institution, was reviewed to identify patients who were evaluated for and/or received plasma exchange for suspected TTP.

View Article and Find Full Text PDF

Objectives: To conduct a clinicopathologic study of male breast carcinoma with Magee equation recurrence score (RS).

Methods: Seventy-four cases of male invasive breast cancers (MBCs) were studied, including 63 hormone receptor (HR)-positive, 10 human epidermal growth factor receptor 2-positive, and one triple-negative breast cancers.

Results: Among 63 HR-positive MBC patients, nine patients developed distal metastasis.

View Article and Find Full Text PDF